Trade Names
Synonyms
Status
Molecule Category Salt-form
UNII N0493335P3
Parent Compound: ELIGLUSTAT

Structure

InChI Key KUBARPMUNHKBIQ-ZBPSDVLKSA-N
Smiles CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.O=C(O)C(O)C(O)C(=O)O
InChI
InChI=1S/2C23H36N2O4.C4H6O6/c2*1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20;5-1(3(7)8)2(6)4(9)10/h2*10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26);1-2,5-6H,(H,7,8)(H,9,10)/t2*19-,23-;/m11./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C50H78N4O14
Molecular Weight 959.19
AlogP 3.43
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 11.0
Polar Surface Area 71.03
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 29.0

Pharmacology

Mechanism of Action Action Reference
Ceramide glucosyltransferase inhibitor INHIBITOR FDA

Target Conservation

Protein: Ceramide glucosyltransferase

Description: Ceramide glucosyltransferase

Organism : Homo sapiens

Q16739 ENSG00000148154

Cross References

Resources Reference
ChEMBL CHEMBL4297066
FDA SRS N0493335P3
PubChem 52918379